Lemaitre Vascular (LMAT) Current Deferred Revenue (2018 - 2019)
Lemaitre Vascular (LMAT) reported Current Deferred Revenue of $188000.0 for Q2 2019, down 80.23% year-over-year from $951000.0 in Q2 2018, and down 48.91% on a QoQ basis from $368000.0 in Q1 2019.
Lemaitre Vascular (LMAT) has 2 years of Current Deferred Revenue data on file, last reported at $188000.0 in Q2 2019.
- Quarterly Current Deferred Revenue fell 80.23% year-over-year to $188000.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $188000.0 (down 80.23% YoY) and the FY2018 annual result came in at $552000.0, changed N/A from the prior year.
- Current Deferred Revenue retreated to $188000.0 in Q2 2019 per LMAT's latest filing, from $368000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $951000.0 in Q2 2018 and bottomed at $188000.0 in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Lemaitre Vascular | 2.28 Bn | 1.91 Bn | 48.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 188,000.00 |
| Mar 31, 2019 | 368,000.00 |
| Dec 31, 2018 | 552,000.00 |
| Sep 30, 2018 | 752,000.00 |
| Jun 30, 2018 | 951,000.00 |